Ampio Pharmaceuticals Inc (AMPE): $21 Target Citi Group - stock Under valu...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Ampio Pharmaceuticals Inc (AMPE)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	20
Posts	1215
Boards Moderated	0
Alias Born	11/28/2012

Re: beambe post# 132

Tuesday, 05/13/2014 6:00:08 PM

Tuesday, May 13, 2014 6:00:08 PM

$21 Target Citi Group - stock Under valued. http://www.theflyonthewall.com/permalinks/entry.php/AMPEid2007455/AMPE-Ampio-initiated-with-a-Buy-at-Citigroup

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent AMPE News

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation • PR Newswire (US) • 04/03/2024 06:33:00 PM
Ampio Announces Voluntary Delisting and SEC Deregistration • PR Newswire (US) • 03/25/2024 09:00:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2024 05:15:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 08:49:00 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/28/2024 08:48:05 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/28/2024 08:47:17 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/28/2024 08:46:20 PM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/28/2024 08:45:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 02:31:23 PM
Ampio Provides Update on Results from Pre-IND Enabling Studies • PR Newswire (US) • 02/14/2024 10:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:31:28 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/25/2024 09:18:53 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/24/2024 10:16:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:20:20 PM
Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions • PR Newswire (US) • 01/11/2024 09:15:00 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/21/2023 09:25:42 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:10:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 01:30:24 PM
Ampio Pharmaceuticals to Present at the Emerging Growth Conference • PR Newswire (US) • 10/31/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 06:10:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 06:56:04 PM
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 • PR Newswire (US) • 10/05/2023 08:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:15:24 PM
Ampio Pharmaceuticals to Present at the Emerging Growth Conference • PR Newswire (US) • 09/26/2023 01:15:00 PM

More AMPE News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow